BioLife Solutions, Inc.BLFSNASDAQ
LOADING
|||
EV to Sales: Premium Valuation
Trending higher, above historical average, strong compound growth.
Left:
||||
Enterprise value to sales ratio
Latest
13.75
↑ 46% above average
Average (9y)
9.43
Historical baseline
Range
High:21.00
Low:2.65
CAGR
+16.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 13.75 | +174.9% |
| 2023 | 5.00 | -52.2% |
| 2022 | 10.46 | -10.5% |
| 2021 | 11.68 | -44.4% |
| 2020 | 21.00 | +85.6% |
| 2019 | 11.32 | +35.5% |
| 2018 | 8.35 | +26.3% |
| 2017 | 6.62 | +149.7% |
| 2016 | 2.65 | -24.4% |
| 2015 | 3.50 | - |